Literature DB >> 1513333

Peroxidase-promoted oxidation and peroxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine. A new pathway for its metabolic degradation.

D Metodiewa1, H B Dunford.   

Abstract

Spectral data provide the first evidence that lactoperoxidase, a model enzyme for most mammalian peroxidases, catalyzed the one-electron oxidation and/or peroxidation of 5,7-dihydroxytryptamine. This process correlates with the production of superoxide radicals as is evident from the observed inhibitory effect of superoxide dismutase on product formation. 5,7-Dihydroxytryptamine is a classical peroxidase-oxidase substrate acting as a one-electron donor for enzyme compounds I, II and III. The one-electron peroxidatic oxidation of this serotonergic neurotoxin, responsible for the selective degeneration of central (5-hydroxytryptamine) neurons, is a fast process requiring measurement on the ms time scale. Attention is drawn to the biochemical and toxicological implications, because this fast reaction results in formation of known cell damaging species: free radicals, superoxide radicals and quinoidal products probably involved in the toxic action of 5,7-dihydroxytryptamine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513333     DOI: 10.1007/bf00229641

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Subcellular distribution of D-amino acid oxidase and catalase in rat brain.

Authors:  G L Gaunt; C de Duve
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

2.  RECONSTITUTION OF ACID-DENATURED CATALASE.

Authors:  T SAMEJIMA; J T YANG
Journal:  J Biol Chem       Date:  1963-10       Impact factor: 5.157

3.  The reactions of horseradish peroxidase, lactoperoxidase, and myeloperoxidase with enzymatically generated superoxide.

Authors:  D Metodiewa; H B Dunford
Journal:  Arch Biochem Biophys       Date:  1989-07       Impact factor: 4.013

4.  Further characterization of human erythrocyte superoxide dismutase.

Authors:  R G Briggs; J A Fee
Journal:  Biochim Biophys Acta       Date:  1978-11-20

5.  5,7-dihydroxytryptamine: improvement in chemical lesioning of indoleamine neurons in the mammalian brain.

Authors:  H G Baumgarten; L Lachenmayer
Journal:  Z Zellforsch Mikrosk Anat       Date:  1972

6.  Mechanisms of action of hydroxylated phenylethylamine and indoleamine neurotoxins.

Authors:  G Cohen; R E Heikkila
Journal:  Ann N Y Acad Sci       Date:  1978-06-12       Impact factor: 5.691

7.  Polarographic measurements of spontaneous and mitochondria-promoted oxidation of 5,6- and 5,7-dihydroxytryptamine.

Authors:  H P Klemm; H G Baumgarten; H G Schlossberger
Journal:  J Neurochem       Date:  1980-12       Impact factor: 5.372

8.  Antioxidant characteristics of some potential anticataract agents. Studies of aspirin, paracetamol, and bendazac provide support for an oxidative component of cataract.

Authors:  A C Woollard; S P Wolff; Z A Bascal
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

9.  Oxidation of 5-hydroxytryptamine and 5,7-dihydroxytryptamine. A new oxidation pathway and formation of a novel neurotoxin.

Authors:  M Z Wrona; D Lemordant; L Lin; C L Blank; G Dryhurst
Journal:  J Med Chem       Date:  1986-04       Impact factor: 7.446

10.  Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

Authors:  A M Palmer; P T Francis; J S Benton; N R Sims; D M Mann; D Neary; J S Snowden; D M Bowen
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.